Prosecution Insights
Prosecution Insights
20 pending office actions • 15 art units • 19 examiners • 0 of 20 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (30%) |
| §103 only | 4 (20%) |
| §102 only | 1 (5%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 2 (10%) |
| Multi-statute (no §101) | 6 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLIENTZ, LEAH H | 2 | 41.8% | +38.6% |
| TON, MARTIN TRUYEN | 1 | 61.8% | +35.0% |
| JACKSON, SHAWQUIA | 1 | 77.9% | -3.3% |
| GUSSOW, ANNE | 1 | 57.3% | +43.0% |
| STEELE, AMBER D | 1 | 59.0% | +9.7% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.1% |
| INAM, SAHAR | 1 | 100.0% | +0.0% |
| PECKHAM, RICHARD GRANT | 1 | 67.2% | +37.0% |
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 31.4% | +32.1% |
| SANTOS, DANIEL JOSEPH | 1 | 75.0% | +28.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18579830 | PHTHALAZINONE-BASED PARP-1 INHIBITORS | INAM, SAHAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18316719 | ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA | JOHANNSEN, DIANA B | 134d overdue |
| 18407998 | USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME | PECKHAM, RICHARD GRANT | 2d overdue |
| 17114433 | PREDICTING AND PREVENTING HYPOGLYCEMIA IN PATIENTS HAVING TYPE 1 DIABETES DURING PERIODS OF INCOGNIZANCE USING BIG DATA ANALYTICS AND DECISION THEORETIC ANALYSIS | GIRI, PURSOTTAM | 14d |
| 18992663 | METHODS AND SYSTEMS FOR TRANS-CERVICAL DELIVERY OF AGENTS | TON, MARTIN TRUYEN | — |
| 18292884 | METHODS FOR SELECTING MELANOMA PATIENTS FOR THERAPY AND METHODS OF REDUCING OR PREVENTING MELANOMA METASTASIS | GUSSOW, ANNE | — |
| 18290740 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | STEELE, AMBER D | — |
| 18290755 | Self-assembling nanomaterial for the detection, imaging, or treatment of cancer | DONOHUE, SEAN R | — |
| 18248045 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | SCHLIENTZ, LEAH H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18407998 | USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME | PECKHAM, RICHARD GRANT | 2d overdue |
| 18992663 | METHODS AND SYSTEMS FOR TRANS-CERVICAL DELIVERY OF AGENTS | TON, MARTIN TRUYEN | — |
| 18292884 | METHODS FOR SELECTING MELANOMA PATIENTS FOR THERAPY AND METHODS OF REDUCING OR PREVENTING MELANOMA METASTASIS | GUSSOW, ANNE | — |
| 18290755 | Self-assembling nanomaterial for the detection, imaging, or treatment of cancer | DONOHUE, SEAN R | — |
| 18269150 | ANTIBACTERIAL ESTER-FREE MONOMERS FOR DENTAL ADHESIVES | KELLY-O'NEILL, YOLANDA LYNNETTE | — |
| 18202463 | SYSTEMS AND METHODS FOR CLASSIFYING OPHTHALMIC DISEASE SEVERITY | SANTOS, DANIEL JOSEPH | — |
| 18248045 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | SCHLIENTZ, LEAH H | — |
| 18042209 | SMALL MOLECULE ALBUMIN BINDERS | SCHLIENTZ, LEAH H | — |
| Art Unit | Apps |
|---|---|
| 3771 | 2 |
| 1618 | 2 |
| 1685 | 1 |
| 1622 | 1 |
| 1627 | 1 |
| 1764 | 1 |
| 2667 | 1 |
| 1682 | 1 |
| 1626 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18992663 | METHODS AND SYSTEMS FOR TRANS-CERVICAL DELIVERY OF AGENTS | TON, MARTIN TRUYEN | 3771 | §102§103§112 | Non-Final OA | — | Pending | Jan 09, 2025 |
| 18795621 | DERIVATIVES OF SOBETIROME | JACKSON, SHAWQUIA | — | §112Other | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18292884 | METHODS FOR SELECTING MELANOMA PATIENTS FOR THERAPY AND METHODS OF REDUCING OR PREVENTING MELANOMA METASTASIS | GUSSOW, ANNE | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18290740 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | STEELE, AMBER D | — | §101§102§103§112DP | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18290755 | Self-assembling nanomaterial for the detection, imaging, or treatment of cancer | DONOHUE, SEAN R | — | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579830 | PHTHALAZINONE-BASED PARP-1 INHIBITORS | INAM, SAHAR | 1622 | §103 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18407998 | USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME | PECKHAM, RICHARD GRANT | 1627 | §101§102§103§112Other | Non-Final OA | 2d overdue | Pending | Jan 09, 2024 |
| 18269150 | ANTIBACTERIAL ESTER-FREE MONOMERS FOR DENTAL ADHESIVES | KELLY-O'NEILL, YOLANDA LYNNETTE | 1764 | §103 | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18202463 | SYSTEMS AND METHODS FOR CLASSIFYING OPHTHALMIC DISEASE SEVERITY | SANTOS, DANIEL JOSEPH | 2667 | §103 | Non-Final OA | — | Pending | May 26, 2023 |
| 18316719 | ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA | JOHANNSEN, DIANA B | 1682 | §101§102§103§112 | Non-Final OA | 134d overdue | Pending | May 12, 2023 |
| 18248045 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | SCHLIENTZ, LEAH H | 1618 | §102§103 | Final Rejection | — | Pending | Apr 05, 2023 |
| 18122605 | SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP) | AGUIRRE, AMANDA L | 1626 | §102 | Final Rejection | — | Pending | Mar 16, 2023 |
| 18025489 | AUXETIC DEVICE DELIVERY APPARATUS AND METHOD | HOUSTON, ELIZABETH | 3771 | §102§103 | Non-Final OA | — | Pending | Mar 09, 2023 |
| 18042209 | SMALL MOLECULE ALBUMIN BINDERS | SCHLIENTZ, LEAH H | 1618 | §102§103§112 | Non-Final OA | — | Pending | Feb 17, 2023 |
| 17997533 | ANTAGONISTS OF GPR39 PROTEIN | JARRELL, NOBLE E | 1699 | §112DP | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17909908 | MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS | TSAY, MARSHA M | 1656 | §101§112 | Final Rejection | — | Pending | Sep 07, 2022 |
| 17753592 | CRISPR-MEDIATED CAPTURE OF NUCLEIC ACIDS | YOUNG, BRIAN ELLIS | 1684 | §103§112 | Non-Final OA | — | Pending | Mar 08, 2022 |
| 17636506 | MODULATION OF T CELL RESPONSES BY UL18 OF HUMAN CYTOMEGALOVIRUS | MIANO, JOSEPH PAUL | 1631 | §103DP | Non-Final OA | — | Pending | Feb 18, 2022 |
| 17616941 | TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELL RESPONSES | BERHANE, SELAM | 1675 | §103 | Final Rejection | 4d overdue | Pending | Dec 06, 2021 |
| 17114433 | PREDICTING AND PREVENTING HYPOGLYCEMIA IN PATIENTS HAVING TYPE 1 DIABETES DURING PERIODS OF INCOGNIZANCE USING BIG DATA ANALYTICS AND DECISION THEORETIC ANALYSIS | GIRI, PURSOTTAM | 2186 | §101§102§103 | Non-Final OA | 14d | Pending | Dec 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial